comparemela.com

Latest Breaking News On - Paolo fiorina - Page 5 : comparemela.com

Sofinnova Partners Announces New Investment in Nephris, an Innovative Biotech Targeting Chronic Kidney Diseases

Pathway to treat type 1 diabetes revealed in study

A new study has identified harmful cellular pathways that prevent insulin production, presenting a drug target for diabetes.

Newly discovered death receptor could help drive type 1 diabetes

Insulin-producing cells in the pancreas carry a death receptor that, when activated, causes the cells to self-destruct. This cellular self-destruct button may in turn contribute to the development of type 1 diabetes, according to a new study in mice and human tissues.

Researchers identify a cellular pathway that causes pancreatic beta cells to die in type 1 diabetes

A central feature of type 1 diabetes is loss of the pancreatic beta cells that make insulin. Researchers led by Paolo Fiorina, MD, PhD, of Boston Children's Hospital and Francesca D'Addio, MD, of the University of Milan now identify a harmful cellular pathway that causes these cells to die.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.